AT
Aclaris Therapeutics Inc
🇩🇪XSTU.8ATGermanyHealthcare
€4.63EURdown -0.13 (-2.73%)OpenEnd of day9:12 AM
Price€4.63-0.13 (-2.73%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US00461U1051
- CUSIP
- Not reported
Company
- Employees
- 69
- Headquarters
- Wayne, United States
- Website
- https://www.aclaristx.com
- CEO
- Dr. Neal S. Walker D.O., M.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- -$0.53
- P/E LTM
- -9.59
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $8.22M-51.05%down year on year
- Net income
- -$75.74M+43.75%up year on year
- Gross margin
- 95.61%+489.27%up year on year
- Free cash flow
- -$62.18M-33.16%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.